— Know what they know.
Not Investment Advice

HZNP NASDAQ

Horizon Therapeutics Public Limited Company
1W: +0.3% 1M: +0.8% 3M: +12.9% 1Y: +71.3% 3Y: +45.2% 5Y: +513.7%
$116.30
Last traded 2023-10-09 — delisted
NASDAQ · Healthcare · Drug Manufacturers - General · $26.6B mcap
#14 of 19
Drug Manufacturers - General
Healthcare · Large Cap · 1 peers
Market Share
0.5%
Top 4 Concentration: 68.4%

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
HZNP Horizon Therapeutics Public Limited Company $27B 51.0 8.5 9.4 13.4 -4.4 7 N/A 71.3
AMRN Amarin Corporation plc $260M -8.6 -6.0 -19.6 -18.1 -15.1 6 BEARISH -25.8

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

HZNP vs Benchmarks

ROIC
HZNP
9.4
Industry
15.2
Gross Margin
HZNP
76.7
Industry
70.8
Op Margin
HZNP
15.1
Industry
19.3
Net Margin
HZNP
13.4
Industry
10.2
Sector
9.8
Revenue Growth
HZNP
-4.4
Sector
9.4
P/E Ratio
HZNP
51.0
Sector
29.7
ROE
HZNP
8.5
Sector
11.5
Piotroski F
HZNP
7.0
Sector
6.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms